Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chas McKhann Insider Profile
4 Followers
Chas McKhann, CCO at Intersect ENT, holds 0.00 shares in Intersect ENT (Ticker: XENT), holds 0.00 shares in Silk Road Medical (Ticker: SILK), holds 0.00 shares in Apollo Endosurgery (Ticker: APEN). Most recently, Chas McKhann ― shares of Intersect ENT on ― for an estimated value of ―.
Chas McKhann Intersect ENT (XENT)CCO
Intersect ENT (XENT)
CCO
Not Ranked
Chas McKhann has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Chas McKhann does not currently own shares as a corporate insider.
A breakdown of Chas McKhann's holdings
Insider Roles
Chas McKhann does not currently hold a role as a corporate insider.
Roles that Chas McKhann holds in companies
Most Profitable Insider Trade
Stock:
Apollo Endosurgery
(APEN)
(APEN)
Rating:Informative Sell
Date:Aug 20, 2021 - Aug 20, 2022
Return:+22.30%
The most profitable trade made by Chas McKhann
Chas McKhann's Trading History
Intersect ENT
―
―
―
$0.00
Apollo Endosurgery
Apr 04, 2023
―
Uninformative Sell
―
$0.00
Silk Road Medical
Sep 18, 2024
―
Uninformative Buy
―
$0.00
List of latest transactions for each holding click on a transaction to see Chas McKhann's performance on stock
You May Also Like
Chas McKhann insider profile FAQ
What is the percentage of profitable transactions made by Chas McKhann?
The percentage of profitable transactions made by Chas McKhann is ―.
What is the average return per transaction made by Chas McKhann?
The average return per transaction made by Chas McKhann is ―.
What stocks does Chas McKhann hold?
Chas McKhann holds: XENT, APEN, SILK stocks.
What was Chas McKhann’s latest transaction?
Chas McKhann latest transaction was an Uninformative Buy of ―.
What was Chas McKhann's most profitable transaction?
Chas McKhann’s most profitable transaction was an Informative Sell of APEN stock on August 20, 2021. The return on the trade was 22.30%.
What is Chas McKhann's role in Intersect ENT?
Chas McKhann's role in Intersect ENT is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.